查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1565707

体外转录模板市场、按产品、按应用、按疾病类型、按国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

In-vitro Transcription Templates Market, By Product, By Application, By Disease Type, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 269 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023年体外转录模板市场规模为2.5143亿美元，2024年至2032年复合年增长率为21.09%。

体外转录模板市场-市场动态

基于 RNA 的疗法和疫苗的需求不断增长以及生物技术研究的不断增加预计也将推动市场需求

基于 RNA 的疗法（包括小干扰 RNA (siRNA) 和反义寡核苷酸 (ASO)）的发展增加了对高品质 RNA 生产的需求。 mRNA 疫苗，例如 Pfizer-BioNTech 和 Moderna 等针对 COVID-19 疾病开发的疫苗，显着提高了人们对体外转录 (IVT) 模板的兴趣。快速设计和生产 mRNA 疫苗的能力使得体外转录在药物开发中变得至关重要。 CRISPR-Cas9 等基因编辑工具的兴起利用体外转录生成嚮导 RNA (gRNA)，这对于基因组编辑应用至关重要。

随着个人化医疗的发展，为癌症免疫疗法等个人化治疗生产客製化 RNA 的能力推动了对高效 IVT 模板技术的需求。生物感测器、生物工程应用和新型生物电路对有效生产 RNA 的需求持续支持对转录模板的需求。此外，製药和生物技术行业正在大力投资研发，这支持了对转录模板的需求。科学家使用体外转录模板来研究基因表现、蛋白质合成和细胞机制。

体外转录模板市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032）每年将以 21.09% 左右的复合年增长率成长

根据产品细分，DNA 模板细分市场预计将在 2023 年显示最大的市场份额，因为它们在驱动转录方面效率更高。

根据应用细分，由于 COVID-19 和其他病毒感染的流行不断增加，疫苗细分是 2023 年领先的应用细分。

根据疾病类型细分，由于肺癌、白血病、乳癌等的盛行率，癌症细分市场是 2023 年最主要的疾病类型细分市场。

从地区来看，由于政府对研究和新药开发的支持，北美是 2023 年的主要收入来源。

体外转录模板市场細項分析：

全球体外转录模板市场根据产品、应用、疾病类型和地区进行细分。

市场依产品分为四大类：DNA模板、RNA模板、模板及转录试剂盒等。 DNA 模板细分市场占据主导地位。 DNA 模板效率高，在定序和转录过程中稳健，有助于市场成长。

市场根据应用分为两类：疫苗和治疗剂。疫苗领域在市场上占据主导地位。这些疫苗主要用于针对病毒感染，比其他类型的疫苗更能有效促进市场成长。

依疾病类型，市场分为五类：癌症、传染病、遗传性疾病、生活型态疾病等。癌症领域在市场上占据主导地位，预计在预测期内将保持其高度主导地位。肺癌、乳癌、白血病的盛行率不断上升，促进了细分市场的成长。

体外转录模板市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲等地区。北美在全球市场中占据最大的收入份额。美国凭藉其完善的生物技术和製药行业，尤其是基于 RNA 的疗法和疫苗的开发，在全球市场占据主导地位。在亚太地区，由于其生物技术行业的不断发展、对基于RNA的疗法的投资增加以及政府对生物技术研发的支持，中国正在迅速成为IVT模板市场的主要参与者。政府对医疗保健创新的日益关注以及与全球製药公司的合作正在推动市场发展。

体外转录模板市场-竞争格局：

体外转录 (IVT) 模板市场竞争非常激烈，生物技术和製药行业的几家主要参与者都专注于基于 RNA 的技术创新。这些公司正在投资开发用于 RNA 生产的高品质转录模板，从而推动 mRNA 疫苗、基于 RNA 的疗法和基因编辑等领域的进步。主要参与者正在与製药公司结盟，为生产基于 RNA 的疫苗和治疗药物提供关键的 IVT 组件。 TriLink、Aldevron 和 Merck 等公司正在大力投资扩大其製造能力，特别是高品质 RNA 生产，以满足对 mRNA 疫苗和 RNA 药物不断增长的需求。

2023年9月，默克成为第一家为mRNA开发、製造、商业化和产品测试提供全面整合服务的CTDMO。

2023年，英国医学研究委员会（MRC）和生物技术和生物科学研究委员会（BBSRC）等研究委员会为RNA生物学、基因组学的基础和应用研究分配了大量资金。

目录

第 1 章：体外转录模板市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 体外转录模板市场片段（依产品）
    • 体外转录模板市场片段（依应用）
    • 依疾病类型分類的体外转录模板市场片段
    • 体外转录模板市场片段（依国家/地区）
    • 按地区分類的体外转录模板市场片段
  • 竞争洞察

第 3 章：体外转录模板主要市场趋势

  • 体外转录模板市场驱动因素
    • 市场驱动因素的影响分析
  • 体外转录模板市场限制
    • 市场限制影响分析
  • 体外转录模板市场机会
  • 体外转录模板市场未来趋势

第 4 章：体外转录模板产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：体外转录模板市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：体外转录模板市场格局

  • 2023 年体外转录模板市占分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：体外转录模板市场 - 按产品

  • 概述
    • 按产品分類的细分市场占有率分析
    • DNA模板
    • RNA模板
    • 模板和转录套件
    • 其他的

第 8 章：体外转录模板市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 疫苗
    • 疗法

第 9 章：体外转录模板市场 - 按疾病类型

  • 概述
    • 按疾病类型分類的细分市场份额分析
    • 癌症
    • 传染病
    • 遗传疾病 生活方式疾病
    • 其他的

第 10 章：体外转录模板市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 体外转录模板北美主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按疾病类型）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 体外转录模板欧洲主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按产品）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模与预测（按疾病类型）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 体外转录模板亚太地区主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按产品）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模与预测（按疾病类型）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 体外转录模板拉丁美洲主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按产品）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模与预测（按疾病类型）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 体外转录模板 中东和非洲主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按产品）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模及预测（按疾病类型）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 体外转录模板产业

  • 竞争仪表板
  • 公司简介
    • Thermo Fisher Scientific
    • Merck KGaA
    • Promega Corporation
    • Agilent Technologies
    • New England Biolabs
    • Takara Bio Inc.
    • Synthego Corporation
    • TriLink BioTechnologies
    • Aldevron
    • Bio-Rad Laboratories
    • GenScript Biotech Corporation
    • Sigma-Aldrich
    • CellScript
    • QIAGEN NV
    • Lucigen Corporation
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV3865

REPORT HIGHLIGHT

In-vitro Transcription Templates Market size was valued at USD 251.43 Million in 2023, expanding at a CAGR of 21.09% from 2024 to 2032.

In-vitro transcription templates are DNA sequences used to synthesize RNA in a controlled laboratory setting outside of a living organism. These templates serve as the blueprints for RNA synthesis and are essential in experiments where researchers want to produce specific RNA molecules.

In-vitro Transcription Templates Market- Market Dynamics

Growing demand from RNA-based therapeutics & vaccines and increasing research in biotech is also expected to propel market demand

The development of RNA-based therapeutics, including small interfering RNA (siRNA) and antisense oligonucleotides (ASOs), has increased demand for high-quality RNA production. mRNA vaccines, like those developed for COVID-19 disease like Pfizer-BioNTech and Moderna, have significantly boosted interest in in-vitro transcription (IVT) templates. The ability to rapidly design and produce mRNA vaccines has made in-vitro transcription crucial in pharmaceutical development. The rise of gene-editing tools like CRISPR-Cas9 uses in-vitro transcription to generate guide RNA (gRNA), which is critical for genome editing applications.

As personalized medicine evolves, the ability to produce tailor-made RNA for individualized treatments like cancer immunotherapies drives the demand for efficient IVT template technology. The need for efficient production of RNA for biosensors, bioengineering applications, and novel biological circuits continues to support the demand for transcription templates. In addition, the pharmaceutical and biotechnology industries are investing heavily in R&D, which supports the demand for transcription templates. Scientists use in-vitro transcription templates to study gene expression, protein synthesis, and cellular mechanisms.

In-vitro Transcription Templates Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 21.09% over the forecast period (2024-2032)

Based on Product segmentation, the DNA templates segment was predicted to show maximum market share in the year 2023, owing to their higher efficiency in driving transcription.

Based on Application segmentation, vaccines segment was the leading Application segment in 2023, due to the growing prevalence of COVID-19 and other viral infections.

Based on Disease Type segmentation, cancer segment was the leading Disease Type segment in 2023, due to prevalence of lung cancer, leukemia, breast cancer, etc.

On the basis of region, North America was the leading revenue generator in 2023, due to the government support in research & new drugs development.

In-vitro Transcription Templates Market- Segmentation Analysis:

The Global In-vitro Transcription Templates Market is segmented on the basis of Product, Application, Disease Type, and Region.

The market is divided into four categories based on Product: DNA templates, RNA templates, templates & transcription kits, and others. The DNA templates segment dominates the market. DNA templates offer high efficiency & are robust in sequencing & transcription process which is contributing to market growth.

The market is divided into two categories based on Application: vaccines and therapeutics. The vaccines segment dominates the market. The vaccines are mainly used in targeting viral infections and are more effective than other type boosting market growth.

The market is divided into five categories based on Disease Type: cancer, infectious diseases, genetic diseases lifestyle diseases, and others. The cancer segment dominates the market and is expected to maintain its high dominance during the forecast period. The growing prevalence of lung, breast cancer, leukemia are supplementing segment growth.

In-vitro Transcription Templates Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America held the largest revenue share in the global market. The U.S. dominates the global market due to its well-established biotechnology and pharmaceutical sectors, particularly in the development of RNA-based therapies and vaccines. In Asia Pacific, China is rapidly emerging as a key player in the IVT template market due to its growing biotech sector, increasing investments in RNA-based therapeutics, and government support for biotechnology R&D. Increased government focus on healthcare innovation and collaborations with global pharma companies are driving the market.

In-vitro Transcription Templates Market- Competitive Landscape:

The In-vitro Transcription (IVT) Templates market is significantly competitive, with several key players across the biotechnology and pharmaceutical industries focusing on innovations in RNA-based technologies. These companies are investing in developing high-quality transcription templates for RNA production, enabling advancements in areas like mRNA vaccines, RNA-based therapeutics, and gene editing. Key players are forming alliances with pharmaceutical companies to supply critical IVT components for the production of RNA-based vaccines and therapeutics. Companies like TriLink, Aldevron, and Merck are heavily investing in expanding their manufacturing capabilities, particularly for high-quality RNA production, to meet the growing demand for mRNA vaccines and RNA-based drugs.

In September 2023, Merck became the first CTDMO to offer fully integrated services for mRNA development, manufacturing, commercialization, and product testing.

In 2023, UK research councils such as the Medical Research Council (MRC) and the Biotechnology and Biological Sciences Research Council (BBSRC) allocated substantial funding for basic and applied research in RNA biology, genomics.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET KEY PLAYERS

  • Thermo Fisher Scientific
  • Merck KGaA
  • Promega Corporation
  • Agilent Technologies
  • New England Biolabs
  • Takara Bio Inc.
  • Synthego Corporation
  • TriLink BioTechnologies
  • Aldevron
  • Bio-Rad Laboratories
  • GenScript Biotech Corporation
  • Sigma-Aldrich
  • CellScript
  • QIAGEN N.V.
  • Lucigen Corporation
  • Others

GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET, BY PRODUCT- MARKET ANALYSIS, 2019-2032

  • DNA templates
  • RNA templates
  • Templates & Transcription Kits
  • Others

GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Vaccines
  • Therapeutics

GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019-2032

  • Cancer
  • Infectious diseases
  • Genetic diseases lifestyle diseases
  • Others

GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. In-vitro Transcription Templates Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. In-vitro Transcription Templates Market Snippet by Product
    • 2.1.2. In-vitro Transcription Templates Market Snippet by Application
    • 2.1.3. In-vitro Transcription Templates Market Snippet by Disease Type
    • 2.1.4. In-vitro Transcription Templates Market Snippet by Country
    • 2.1.5. In-vitro Transcription Templates Market Snippet by Region
  • 2.2. Competitive Insights

3. In-vitro Transcription Templates Key Market Trends

  • 3.1. In-vitro Transcription Templates Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. In-vitro Transcription Templates Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. In-vitro Transcription Templates Market Opportunities
  • 3.4. In-vitro Transcription Templates Market Future Trends

4. In-vitro Transcription Templates Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. In-vitro Transcription Templates Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. In-vitro Transcription Templates Market Landscape

  • 6.1. In-vitro Transcription Templates Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. In-vitro Transcription Templates Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. DNA templates
    • 7.1.3. RNA templates
    • 7.1.4. Templates & Transcription Kits
    • 7.1.5. Others

8. In-vitro Transcription Templates Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Vaccines
    • 8.1.3. Therapeutics

9. In-vitro Transcription Templates Market - By Disease Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Disease Type, 2024 & 2032 (%)
    • 9.1.2. Cancer
    • 9.1.3. Infectious diseases
    • 9.1.4. Genetic diseases lifestyle diseases
    • 9.1.5. Others

10. In-vitro Transcription Templates Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. In-vitro Transcription Templates Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. In-vitro Transcription Templates Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. In-vitro Transcription Templates Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. In-vitro Transcription Templates Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. In-vitro Transcription Templates Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- In-vitro Transcription Templates Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Thermo Fisher Scientific
    • 11.2.2. Merck KGaA
    • 11.2.3. Promega Corporation
    • 11.2.4. Agilent Technologies
    • 11.2.5. New England Biolabs
    • 11.2.6. Takara Bio Inc.
    • 11.2.7. Synthego Corporation
    • 11.2.8. TriLink BioTechnologies
    • 11.2.9. Aldevron
    • 11.2.10. Bio-Rad Laboratories
    • 11.2.11. GenScript Biotech Corporation
    • 11.2.12. Sigma-Aldrich
    • 11.2.13. CellScript
    • 11.2.14. QIAGEN N.V.
    • 11.2.15. Lucigen Corporation
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us